MEGHAN KOHUTH: Open Payments
NPI 1447937651 · PHOENIXVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 16 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,609 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 2 | $93 |
| ABBVIE INC. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| Amgen Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $22 |
| BETA BIONICS, INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: ACCRUFER, VRAYLAR, Veozah, OTEZLA, GEMTESA, JARDIANCE, INJECTAFER, REXULTI.
Industry payments across PA — which companies pay providers there.
